Deoria (UP), Jun 22 (PTI) A man, who allegedly issued death threats to Shalabh Mani Tripathi, the BJP MLA from Uttar Pradesh’s Deoria Sadar Assembly seat, and a local journalist was arrested here on ...

A man suspected of issuing death threats to Shalabh Mani Tripathi, a BJP MLA from Deoria, along with a local journalist, was apprehended by authorities on Sunday, according to police sources. Police ...

I don’t self-censor in US; the more unhinged, the better: Zarna Garg Bestselling author, actor, and comedian Zarna Garg discusses her meteoric rise as a prominent South Asian voice in Western ...

Amit Srivastava, Founder and CEO of Nutrify Today On June 12, 2025, India Chambers appointed Amit Srivastava, Founder and CEO of Nutrify Today, to the Governing Board of its Rural Economic Forum as ...

Shalabh Shrivastava, the senior vice president of Driver Org at Swiggy, has quit the company, according to sources aware of the development. Before joining Swiggy in November last year, Shrivastava ...

Srivastava also questioned the timing of Israel’s strike, which came just before the sixth round of US-Iran nuclear talks. “The timing was very odd, and it raises many questions,” he said. He also ...

Prostate and bladder cancer in men can be prevented with the right lifestyle practices. Around Father's Day 2025 is a good time to learn such tips. | Health ...

He was arrested on May 29. Singh moved a bail plea through advocate Shalabh Saxena, submitting that during searches at his homes, the total cash found was merely Rs 22,000.

CID 2 cast Shivaji Satam, Aditya Srivastava and others bid an emotional farewell to Parth Samthaan CID, the iconic crime investigation series that defined a generation of television in India ...

Kalyani Srivastava leaves Ogilvy India to become Chief Business Officer at Creativeland Asia, bringing extensive experience from her previous roles in the advertising and consulting industry.

Objective In PAISLEY, a 48-week, phase II, randomised controlled trial that assessed deucravacitinib in patients with active SLE, all primary and secondary endpoints were met with the deucravacitinib ...